Arsenic (As) biomethylation is an important component of the As biogeochemical cycle that can influence As toxicity and mobility in the environment. Biomethylation of As is catalyzed by the enzyme arsenite (As[III]) S-adenosylmethionine methyltransferase (ArsM). To date, all identified ArsM orthologs with As(III) methylation activities have four conserved cysteine residues, which are thought to be essential for As(III) methylation. Here, we isolated an As(III)-methylating bacterium, Bacillus sp. CX-1, and identified a gene encoding a S-adenosylmethionine methyltranserase termed BlArsM with low sequence similarities ( 39%) to other ArsMs. BlArsM has six cysteine residues (Cys10, Cys11, Cys145, Cys193, Cys195 and Cys268), three of which (Cys10, Cys145 and Cys195) align with conserved cysteine residues found in most ArsMs. BlarsM is constitutively expressed in Bacillus sp. CX-1. Heterologous expression of BlarsM conferred As(III) resistance. Purified BlArsM methylated both As(III) and methylarsenite (MAs[III]), with a final product of dimethylarsenate (DMAs [V]). When all six cysteines were individually altered to serine residues, only C145S and C195S derivatives lost the ability to methylate As(III) and MAs(III). The derivative C10S/C11S/C193S/C268S was still active. These results suggest that BlArsM is a novel As(III) S-adenosylmethionine methyltransferase requiring only two conserved cysteine residues. A model of As(III) methylation by BlArsM is proposed.
Introduction
Arsenic (As) is a toxic and carcinogenic metalloid that is a widely distributed in the environment. Arsenic enters the environment primarily from geological sources and anthropogenic activities, such as mining and smelting, extraction of As-contaminated groundwater, uses of Ascontaining agrochemicals and animal feed additives . Chronic exposure to As can cause serious diseases, such as cancers, cardiovascular disease and diabetes . It has been estimated that more than 150 million of people worldwide, mainly in South and Southeast Asia, are suffering from As poisoning due to elevated levels of As in drinking water (Brammer and Ravenscroft, 2009 ). In addition to drinking water, dietary intake is another important exposure route of As for humans. Due to its potential harmful effects on human health, As is ranked the first in the Agency for Toxic Substances and Disease Registry (ATSDR) 2015 substance priority list (http://www.atsdr. cdc.gov/SPL/index.html).
Arsenic is present in the environment in various inorganic and organic forms. The mobility and toxicity of As are strongly dependent on its chemical species. Inorganic arsenate (As [V] ) and arsenite (As [III] ) are the most common forms of As in the environment, with the latter being more mobile and toxic than the former (Kang et al., 2012; Zhu et al., 2014) . Arsenic can be biomethylated into different organic species containing one to four methyl groups (Cullen and Reimer, 1989; Zhu et al., 2014) . The toxicity of methylated As species depends on the oxidation state of As, with trivalent As species being much more toxic than pentavalent As species (Petrick et al., 2000; Styblo et al., 2000) . Some methylated As species, such as dimethylarsine and trimethylarsine are volatile.
Biomethylation of As(III) is widespread in nature and has been observed in mammals including rat (Lin et al., 2002) and human (Waters et al., 2004) , fish (Hamdi et al., 2012) , protozoan (Ye et al., 2014) , algae (Qin et al., 2009) , bacteria (Qin et al., 2006; Zhang et al., 2015; Huang et al., 2016) , fungi (Bentley and Chasteen, 2002) and archaea (Wang et al., 2014) . This biological transformation is catalyzed by the As(III) S-adenosylmethionine methyltransferase enzymes, which are termed ArsM in microbes (Qin et al., 2006) and AS3MT (Cyt19) in mammals (Lin et al., 2002; Waters et al., 2004) . The enzymes catalyze sequential transfers of the methyl group from SAM to As(III), producing mono-, di-, tri-or even tetra-methylarsenical species. Dheeman et al. (2014) proposed a pathway in which As undergoes oxidation and reduction as enzyme-bound intermediates but is released from the enzyme as trivalent methylarsenicals. It should be noted that the trivalent methylarsenicals released from the enzyme are unstable and can be easily oxidized to the corresponding pentavalent species, which are commonly detected in the environment. In the proposed pathway four conserved cysteine residues participate. The role of these conserved cysteine residues in As(III) methylation has been examined in detail in CmArsM from Cyanidioschyzon sp. isolate 5508 (Marapakala et al., , 2015 and human hAS3MT (Dheeman et al., 2014) . The N-terminal two cysteine residues, termed CysA and CysB, are involved in As(III) methylation but not required for methylarsenite (MAs[III] ) methylation (Dheeman et al., 2014; Marapakala et al., 2015) . The C-terminal two cysteine residues, termed CysC and CysD, form the As(III) binding site and are absolutely required for catalysis. Thus mutants in CysC and/or CysD of human AS3MT are catalytically inactive, while mutants in CysA and/or CysB methylate MAs(III) rapidly but methylate As(III) very slowly (Dheeman et al., 2014) .
To date, more than 6000 sequences for genes encoding ArsMs are included in the NCBI database, with the majority of them from prokaryotic and eukaryotic microbes. In microbes, As(III) methylation is thought to be a detoxification process. This is supported by the findings that heterologous expression of arsM in an E. coli strain lacking the As resistance operon enhances its resistance to As(III) (Qin et al., 2009; Zhang et al., 2015; Huang et al., 2016) , and deletion of arsM from Pseudomonas alcaligenes and Tetrahymena pyriformis results in As(III) sensitivity (Ye et al., 2014; Zhang et al., 2015) . In addition, the expression of arsM genes are usually induced by As(III) exposure (Yin et al., 2011; Kuramata et al., 2015; Huang et al., 2016) , likely regulated by an adjacent arsR gene encoding an As(III)-responsive repressor (Qin et al., 2006; Ye et al., 2012) . A common property of bacterial, algal and mammalian ArsMs studied to date is the presence of the four conserved cysteine residues (Marapakala et al., 2015; Yang and Rosen, 2016; Chen et al., 2017) , CysA, B, C and D (Chen et al., 2017) . However, not all ArsMs contain four conserved cysteine residues. For example, Chen et al. (2017) reported that AfArsM of Aspergillus fumigatus contains only CysB, CysC and CysD. They showed that AfArsM was able to methylate MAs(III), but did not methylate As(III) at more than a few percent of the rate of four-cysteine enzymes.
Due to the use of As-containing substances in animal feeds for growth promotion, As concentrations in animal manures and manure composts are often elevated (Yang et al., 2017) . Arsenic speciation analysis of manure composts showed considerable amounts of methylated As species, especially dimethylarsenate (DMAs[V]) (Yang et al., 2017) . DMAs(V) and, to a less extent, methylarsenate (MAs[V]), were formed during composting of manures, with the formation of methylated arsenicals being correlated with the copy number of microbial arsM genes (Zhai et al., 2017) . It therefore appears that As biomethylation is an important process of As transformation during the composting process of animal manures. However, microbes responsible for this process have not been reported before. In this study, we isolated a Bacillus strain from a manure compost with a high capacity of As methylation. We further characterized the ArsM from this bacterium and showed that it is unusual in requiring only two conserved cysteine residues for As(III) methylation.
Results
Isolation and identification of an As(III) methylating bacterial strain CX-1 In this study, an As(III)-methylating bacterium, strain CX-1, was isolated from an As-contaminated compost sample obtained from a composting factory in Jiangsu province, China (Yang et al., 2017) . This isolate showed a strong capacity for As(III) methylation, transforming nearly all of the As(III) (10 lM) in the medium into DMAs(V) after 24 h (Supporting Information Fig. S1 ). Cells of this isolate were observed under a scanning electron microscope (SEM) as rod-shaped and nonflagellated (Supporting Information Fig. S2 ). Based on 16S rRNA gene sequence analysis, this isolate showed the highest sequence similarity (99%) to Bacillus licheniformis (Supporting Information Fig. S3 ). Thus, based on the data from the morphological and phylogenetical characterization, strain CX-1 was identified as a Grampositive Bacillus strain. The strain had been deposited in the China Center for Type Culture Collection (CCTCC) under the accession number AB2016311.
Sequence analysis of the arsM gene from Bacillus sp.
CX-1
By sequencing the draft genome of strain CX-1, an ArsM homolog encoding gene designated BlarsM was identified. Unlike every other arsM studied to date (Ye et al., 2012) , BlarsM is not located downstream of a putative arsR gene encoding an As(III)-responsive transcriptional repressor. Instead, it is located distantly upstream of arsR with a $9 kb interval region containing seven putative genes (Fig. 1A) . The first three genes close to BlarsM are encoded on the opposite strand and putatively encode a radical SAM protein, a cobalamin biosynthesis protein and a membrane protein in turn. These are followed by four putative genes encoding a MarR family transcriptional regulator, a phosphinothricin acetyltransferase (Pat), a hypothetical protein and a FAD-dependent pyridine nucleotide-disulfide oxidoreductase respectively. In addition, on the upstream (16 bp) of BlarsM exists a putative gene annotated as encoding a phosphoribosylglycinamide synthetase (GARS) (Fig. 1A) . Promoter analysis showed that BlarsM and the GARS gene appear to be organized in the same transcription unit with a promoter located just upstream of the GARS encoding gene. The 271-residue encoding product of BlarsM (BlArsM) shares significant, but very low, sequence identity ( 39%) with the annotated ArsMs in the NCBI database. It exhibits 39% identity to the ArsM of Candidatus Gottesmanbacteria bacterium CG1_02_37_22 (GenBank accession no. OIO14348.1), 24% identity to the eukaryotic Aspergillus fumigatus ArsM (AfArsM1), and 19% identity to the human AS3MT arsenic methyltransferase. Compared with other seven typical orthologs, BlArsM contains only three of the four conserved cysteines (in positions 10, 145 and 195, corresponding to CysA, CysC and CysD) , with the second conserved cysteine (CysB) absent (Fig.  2) . In addition, a type 11 methyltransferase in Bacillus aryabhattai PHB10 (Supporting Information Fig. S3 ) is a close homolog of BlArsM (74% identity) and also contains only three conserved cysteines (CysA, CysC and CysD). This high similarity suggests a close evolutionary relationship.
Transcription of BlarsM in strain CX-1
Real-time qPCR (RT-qPCR) was performed with mRNA derived from the exponential phase cells of strain CX-1 after exposure to different concentrations of As(III) (0-500 lM). The results showed that the BlarsM gene was transcribed in the absence of As(III) (Fig. 1B) . Meanwhile, no significant changes in the transcription efficiency of BlarsM were observed after As(III) exposure (Fig. 1B) , indicating that the expression of BlarsM in strain CX-1 is not inducible by As(III).
BlArsM confers resistance to As(III)
To examine if BlArsM could confer As(III) resistance in E. coli, the BlarsM gene was cloned and expressed in E. coli strain AW3110 (Carlin et al., 1995) , which is an As(III)-hypersensitive strain resulting from the deletion of the chromosomal arsRBC operon of E. coli strain W3110 and has no arsM homolog. When cultured in LB medium without As(III), the recombinant cells bearing the plasmid pET29a-BlarsM and the control vector grew normally, with the former growing slightly better than the latter. At 50 lM As(III), cells expressing BlarsM still grew normally, reaching to nearly half of the cell density in the As(III)-free treatment, whereas the control cells showed very weak growth. At 70 lM As(III), growth of the control cells was almost completely arrested, whereas cells expressing BlarsM could still grow at a very low rate (Fig. 3A) . These results show that expression of the BlarsM gene confers As(III) resistance in E. coli AW3110. 
As(III) methylation and volatilization by E. coli AW3110 expressing BlarsM
After 24 h of incubation, As species in the culture medium was quantitatively determined by highperformance liquid chromatography (HPLC)-inductively coupled plasma mass spectrometry (ICP-MS). When cells expressing BlarsM were incubated with 10 lM As(III), 95% of As(III) was transformed to nonvolatile methylarsenicals, mainly as DMAs(V) (93% of the total As in the culture medium) and very small amounts of MAs(V) and trimethylarsine oxide (TMAs[V]O) (Fig. 3B ). Volatile As species from the assay were collected in AgNO 3 impregnated chemotraps and analyzed by HPLC-ICP-MS. Traces of dimethylarsine (DMAs[III]H) and trimethylarsine (TMAs[III]) were found, which were detected as DMAs(V) and TMAs(V)O respectively, due to the oxidation by AgNO 3 in the chemotrap (Fig. 3C) . At 24 h, the cells produced about 6 ng As of volatile methylarsines, accounting for only 0.08& of the initial total As. By contrast, neither methylated As species nor volatilized methylarsines were observed in the control treatment ( Fig. 3B and C ). These results demonstrate the ability of the BlarsM gene product to catalyze As(III) methylation.
In vitro enzymatic reaction by purified BlArsM
To further investigate the As methylation ability in vitro, BlArsM was expressed in E. coli BL21 (DE3) and purified by Ni-NTA agarose column. The apparent molecular mass of purified BlArsM identified by SDS-PAGE was consistent with the predicted mass (approximately 32 KDa) based on the amino acid sequence (Supporting Information Fig. S4 ). The time course of As(III) methylation was determined in an assay solution containing 1.5 lM enzyme, 12 lM As(III), 8 mM GSH and 1 mM S-Adenosyl-L-methionine (SAM) (substrate:enzyme ratio 5 8; Fig. 4A ). Purified BlArsM converted 70% of As(III) to MAs and DMAs after 12 h, with DMAs being the predominant product. Here DMAs and MAs are used as general designations for the sum of trivalent and pentavalent species because all arsenicals were oxidized to their pentavalent forms by the addition of H 2 O 2 to terminate the reactions. This is necessary because oxidation with H 2 O 2 enhances recovery of enzyme-bound species (Dheeman et al., 2014) . The methylation process was slow initially, with MAs and DMAs being formed after 1 h. The MAs concentration increased slowly. After 12 h only 4% of the total As was found as MAs. The concentration of DMAs increased more or less linearly over that time period and accounted for 66% of the total As in the assay solution at 12 h (Fig. 4A) . When the concentration of purified BlArsM added to the assay solution was increased by fivefold (substrate:enzyme ratio 5 1.6), the reaction rate of As(III) methylation accelerated markedly. Within 3 h nearly all of the As(III) in the assay solution was converted to methylated arsenicals, of which 97%, 3% and 0.2% were present as DMAs, MAs and TMAs(V)O A. Growth of cells bearing vector plasmid pET29a(1) or pET29a-BlarsM in LB medium with 0, 50 or 70 lM As(III) at 378C. Absorbance (OD) was monitored at 600 nm. B. Quantitative analysis of As speciation in the culture medium by HPLC-ICP-MS. Data are means 6 SD (n 5 3). C. HPLC-ICP-MS chromatograms of trapped volatile arsenic species. Biomethylation of As(III) by E. coli cells was assayed in LB medium with 10 lM As(III) and 24 h incubation. respectively (Fig. 4B) . A further experiment was conducted using MAs(III) as the substrate for BlArsM (substrate:enzyme ratio 5 8). MAs(III) was methylated to DMAs much more rapidly than As(III) at the same substrate:enzyme ratio ( Fig. 4A and C) . Within 3 h, 83% of MAs(III) had been converted to DMAs (Fig. 4C) .
The human hAS3MT is able to methylate As(III) using cysteine (Cys) or the artificial reductant tris(2-carboxyethyl)phosphine (TCEP) in the absence of GSH (Dheeman et al., 2014) . BlArsM was also able to methylate As(III) in the presence of Cys without GSH (Supporting Information Fig. S5 ). In contrast, BlArsM was not able to methylate As(III) in the presence of TCEP without GSH (Supporting Information Fig. S5 ), suggesting that thiol ligands such as GSH or Cys are required.
Role of cysteine residues in As(III) and MAs(III) methylation
There are three conserved cysteine residues (Cys10, Cys145 and Cys195) and three non-conserved cysteines (Cys11, Cys193 and Cys268) in BlArsM (Fig. 2) . To investigate the role of these cysteine residues in As(III) methylation, each was individually altered to a serine residue. When the six mutated derivatives were expressed in E. coli BL21 (DE3), cells expressing the C145S and C195S mutants lost the ability to methylate As(III) completely, whereas the C10S, C11S, C193S and C268S mutants exhibited similar activities of As(III) methylation to the wild-type (Fig. 5A) . Subsequently, each of the three conserved cysteine mutant proteins (C10S, C145S and C195S) and the C10S/C11S/C193S/ C268S derivative were purified and used for in vitro assay of the methylation activity. Purified derivatives C10S and C10S/C11S/C193S/C268S methylated both As(III) and MAs(III), but neither the C145S nor the C195S mutated enzymes exhibited any measurable methylation activity for As(III) or MAs(III) (Fig. 5B  and C) . These results support a role for only two conserved cysteine residues, Cys145 and Cys195, in As(III) and/or MAs(III) methylation. In contrast, conserved residue Cys10 and the other three non-conserved cysteine residues are not essential for methylation of As(III) and/ or MAs(III).
Compared with all other ArsMs studied to date, BlArsM is unusual in not having a conserved cysteine residue at position 50 (CysB), where it is replaced by a proline residue (Fig. 2) . To investigate the effect of the presence of CysB on the methylation activity, Pro50 was substituted by a cysteine residue. The rate of As(III) methylation by the purified BlArsM P50C derivative was not significantly different from that by the wild-type BlArsM (Supporting Information Fig. S6 ), demonstrating that whether CysB is present or not has no significant effect on the As(III) methylation activity of BlArsM.
Homology model of BlArsM
Structure and surface models of BlArsM (Fig. 6A and B) were constructed based on the unliganded structure of A. Methylation of 12 lM As(III) by 1.5 lM purified BlArsM. B. Methylation of 12 lM As(III) by 7.5 lM purified BlArsM. C. Methylation of 12 lM MAs(III) by 1.5 lM purified BlArsM. Each reaction mixture (10 ml) contained 1 mM SAM and 8 mM GSH and was incubated at 308C. The reactions were terminated by the addition of 10% (v/v) H 2 O 2 and As speciation was determined by HPLC-ICP-MS. Data are means 6 SD (n 5 3).
the CrArsM from Chlamydomonas reinhardtii. The conserved residue Cys10 is not included in the models because it is not visible in any of the structures in the Protein Data Bank (PDB). The two conserved cysteine residues Cys145 and Cys195 are in close propinquity and form an As(III) binding site, with the arsenic atom 2.0 and 2.4 Å from the sulfur atoms of Cys145 and Cys195 respectively. GSH forms the third ligand with As with the sulfur atom of GSH orienting toward the bound As(III) at approximately 2.4 Å distance (Fig. 6A and B ). The surface model shows that GS -can actually fit into the active site of BlArsM (Fig. 6B ). This result is consistent with the hypothesis proposed by Marapakala et al. (2012) that As(III)GS is the donor of As to ArsM.
Discussion
Arsenic is biomethylated during composting of animal manures, which often contain elevated levels of As due to the use of As-containing additives to animal feed (Yang et al., 2017; Zhai et al., 2017) . However, little is known about the nature of microbes involved in this process. In the present study, we isolated a Bacillus strain (CX-1) from a manure compost capable of methylating inorganic As(III) to DMAs(V) (Supporting Information Fig. S1 ). We further identified and characterized a novel As(III) S-adenosylmethionine methyltransferase from Bacillus sp. CX-1 (BlArsM), which appears to be unusual in several aspects compared with other ArsMs reported previously. First, the gene for BlAsrM is not contained in an ars operon. Second, BlArsM has a low sequence identity ( 39%) with annotated ArsMs in the NCBI database. Third, BlArsM is not controlled by an arsR gene (Fig. 1A ) and is not inducible by As(III) (Fig. 1B) but, rather, in Bacillus sp. CX-1, expression of BlarsM is constitutive. In spite of these differences, it has properties similar to typical ArsMs. For example, heterologous expression of BlarsM in E. coli AW3110 conferred tolerance to As(III), and cells expressing the BlarsM gene methylated As(III) (Fig. 3) . Whether BlArsM plays a role in As(III) detoxification in Bacillus sp. CX-1 remains to be investigated. The results of in vitro assays using purified BlArsM protein confirmed the ability of BlArsM to methylate As(III) (Figs 4 and 5) . DMAs was the primary product of As(III) methylation. The product is predicted to be DMAs(III) (Dheeman et al., 2014; Marapakala et al., 2015) , but the oxidation state of product could not be determined, first because DMAs(III) is unstable, and second because the reactions were terminated with H 2 O 2 , which oxidized all arsenicals to pentavalency. In addition, only small amounts of volatile arsenicals were produced. However, the rate of As(III) methylation was A. In vivo methylation of As(III) by BlArsM and its mutants. Cells of E. coli BL21(DE3) bearing vector plasmid pET29a(1) or expressing wild-type gene or cysteine mutant genes were grown for 24 h in LB medium with 10 lM As(III), 0.3 mM IPTG and 50 lg ml 21 kanamycin at 378C. B. Methylation of As(III) by purified wild-type and four cysteine mutants. C. Methylation of MAs(III) by purified wild-type and four cysteine mutants. Methylation of As(III) or MAs(III) was assayed at 308C after 12 h with 10 lM As(III) or MAs(III), 1.5 lM BlArsM, 1 mM SAM and 8 mM GSH. The reactions were terminated by the addition of 10% (v/v) H 2 O 2 and the filtered samples were analyzed by HPLC-ICP-MS. quite slow in the in vitro assays. In comparison, the rate of methylation of MAs(III) to DMAs(V) catalyzed by BlArsM was much faster (Fig. 4A and C) , suggesting that progressing from the first methylation is a ratelimiting step in the catalytic cycle (Dheeman et al., 2014; Marapakala et al., 2015) .
It has been suggested that four conserved cysteine residues in ArsMs are required for As(III) methylation, while only two conserved cysteines (CysC and CysD) are essential for MAs(III) methylation (Yang and Rosen, 2016) . However, there are only three conserved cysteine residues in BlArsM, with the second conserved cysteine (CysB) missing (Fig. 2) . When the three conserved cysteines and three other non-conserved cysteines in BlArsM were individually replaced with serine, only the C145S and C195S derivatives lost the ability to methylate As(III) or MAs(III) (Fig. 5) . Meanwhile, the mutant with only two conserved cysteines (Cys145 and Cys195) was still active. These results suggest that only the conserved cysteines at the 145th and 195th positions (CysC and D respectively) are essential for As(III) and MAs(III) methylation. Furthermore, replacing the missing CysB at the 50th position did not lead to a gain of function of BlArsM (Supporting Information  Fig. S6 ), suggesting that CysB is also not essential. It is possible that the correct position of CysB may not be the 50th position and placing CysB in other positions could enhance the rate of As(III) methylation, which requires further investigations. The finding that CysC and D are required for MAs(III) methylation is in agreement with previous studies Dheeman et al., 2014; Marapakala et al., 2015; Chen et al., 2017) . However, our results that CysC and D are also the only two conserved cysteines essential for As(III) methylation is different from previous reports (Dheeman et al., 2014; Marapakala et al., 2015; Chen et al., 2017) . It should be noted that in those previous studies As(III) methylation was assayed over a short reaction time (0.5-3 h) only. During early times of As(III) methylation the product, MAs(III), remains on the BlArsM were constructed based on the structure of unliganded Chlamydomonas reinhardtii (CrArsM) (PDB ID: 5EVJ) structure. The location of conserved residues Cys145 and Cys195 are shown as a ball and stick representation. As(III) was manually modeled bound to the two conserved residues using bond distance from As(III)-bound CrArsM structure. GSH (in ball and stick) occupies its binding site with its sulfur (yellow ball) atom poised to be donated to the arsenic (purple ball) atom. (C) reaction model of BlArsM is proposed as follows: (1) In the first step of As(III) methylation BlArsM binds As(III) in a series of two thiols transfer reactions from As(GS) 3 ; (2) the thiol of the enzyme-bound As(III) intermediate is replaced by the methyl group of SAM; (3) the Cys145 thiol is regenerated and the enzyme-bound As(III) intermediate gets another methyl group from SAM; (4) releasing the major product DMAs(III) and regenerating the enzyme. In air, DMAs(III) is non-enzymatically oxidized to DMAs(V).
enzyme, and its dissociation is proposed to be a ratelimiting step in the overall reaction (Dheeman et al., 2014; Marapakala et al., 2015) . In our study, very little As(III) methylation was detected during the first hour of the in vitro assay with wild-type BlArsM, suggesting that progression to the second methylation is rate-limiting for BlArsM as well. The rate of reaction increased noticeably after the first hour and proceeded at a constant rate during the subsequent period up to 12 h (Fig. 4A) . We predict that previously reported ArsMs with the first two conserved cysteines mutated would also methylate As(III) if given longer reaction time.
The structure of CmArsM from the thermophilic eukaryotic alga Cyanidioschyzon merolae has been determined using X-ray crystallography (Ajees et al., 2012; Marapakala et al., 2015) . The study of Ajees et al. (2012) shows that the conserved cysteine residues C and D are directly involved in the binding of As(III). CysA and CysB have been proposed to be involved in keeping the enzyme-bound arsenical intermediate reduced, so how does BlArsM catalyze As(III) methylation with only two essential cysteine residues? To reconcile the results from our study and the model proposed by Dheeman et al. (2014) and Marapakala et al. (2015) , we propose that Cys145 and Cys195 on BlArsM provide two thiol ligands, and non-protein thiols in cells mainly as GSH provide a third ligand for As(III) binding (Fig. 6C ). In the cytosol, As(III) is likely to be complexed with three GSHs as As(GS) 3 , which has higher affinity to ArsM enzymes than inorganic As(III) (Hayakawa et al., 2005) . After As(GS) 3 reacts with BlArsM, two GSHs that bind As(III) are replaced by Cys145 and Cys195 to allow methylation to proceed. Additional GSH might provide the reducing potential to keep the bound arsenical intermediate in a reduced form, substituting for the difulfide bond formed between CysA and CysB (Dheeman et al., 2014; Marapakala et al., 2015) . This model is supported by the observations from the homology structure models of BlArsM (Fig. 6A and B) and could explain the catalytic ability of BlArsM for As(III) methylation, albeit at a relatively low rate. It also explains that BlArsM can methylate MAs(III) efficiently because only two ligands are required for its binding, which are provided by Cys145 and Cys195. It is not unusual for As(III) to be bound by thiol groups from two different molecules. For example, complexes of As(III) bound by both phytochelatin and glutathione are detected in plant cells (Raab et al., 2005; Liu et al., 2010) . When GSH was replaced with the artificial reductant TCEP, which provides no ligand for As(III) coordination, no As(III) methylation took place with BlArsM, supporting the model that GSH is required for As(III) methylation catalyzed by BlArsM. In contrast, ArsMs with four conserved Cys residues can initiate As(III) methylation in the presence of the non-thiol reductant TCEP without GSH (Dheeman et al., 2014) .
What is the relationship of BlArsM to other previously characterized As(III) SAM methyltransferases? It is novel in several ways. Its gene is not in an ars operon and not regulated by an ArsR As(III)-responsive repressor. It requires only CysC and CysD for rapid methylation of MAs(III) and slow methylation of As(III). AfArsM from Aspergillus fumigatus is similar, having only three conserved cysteine residues, CysB, CysC and CysD (Chen et al., 2017) . It rapidly methylates MAs(III) but has negligible methylation of As(III). In that report the authors speculated that the ancestor of As(III) SAM methyltransferases might have only CysC and CysD, which would be sufficient for methylation of MAs(III), and gradually evolved into three and four cysteine ArsMs. We propose that BlArsM is descended from this ancestral As(III) SAM methyltransferase and is either in the line of evolution of four-cysteine ArsMs or a branch of the original lineage. In either case it deserves the ArsM designation.
In conclusion, we have identified a novel As(III) Sadenosylmethionine methyltransferase from Bacillus sp. CX-1 that is constitutively expressed and requires only two conserved cysteine residues for As(III) methylation. Although BlArsM appears to have a lower rate of methylation of As(III) than MAs(III), it may catalyze the methylation of both substrates because As(III) is much more abundant than MAs(III) in the environment. Our study highlights the diversity and evolution of As(III) S-adenosylmethionine methyltransferases with regard to their sequences, transcriptional regulation and catalytic functions, and broadens the understanding of the functions of conserved cysteines in ArsMs in As(III) and MAs(III) methylation.
Experimental procedures

Chemicals
All reagents including As(III), As(V) and DMAs(V) were purchased from Sigma-Aldrich (Mainland, China) unless otherwise mentioned. MAs(V) was purchased from Sunlida (Nanjing, China). MAs(III) was prepared as previously described . TMAs(V)O was obtained as a gift from Dr. Guo-Xin Sun (Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, China).
Isolation and identification of strain CX-1
One strain with As(III) methylation ability was isolated from an As-contaminated compost sample and named CX-1, and its abilities for As(III) methylation and volatilization were determined qualitatively as described below. Briefly, A novel ArsM requires only two conserved cysteines 273 overnight cultured cells were diluted to OD 600 % 0.01 in 250 ml flasks with 100 ml LB medium (10 g l 21 tryptone, 5 g l 21 yeast extract and 10 g l 21 NaCl) with or without 10 lM As(III). After 24 h of growth at 378C and 200 rpm, cultures were sampled and centrifuged at 12,000 rpm for 2 min. The resulting supernatants were filtered through 0.22 lm MCE syringe filters (ASD, China). The filtered solutions were analyzed for As species using HPLC-ICP-MS as described previously (Huang et al., 2015) . The cell morphology was observed by SEM (S-3000N, Hitachi) . The 16S rRNA gene was obtained by PCR using the primer pair 27F/1492R (Supporting Information Table S1 ). The sequence was aligned with those of 14 related strains in the NCBI database and a neighbor-joining phylogenetic tree was constructed using MEGA 5.0.
Cloning and functional characterization of the arsM gene
Total DNA was extracted using the CTAB method described by Smith et al. (1989) and used for draft genome sequencing in Majorbio Co., Ltd. (Shanghai, China). From the draft genome, a putative type 11 methyltransferase gene (BlarsM) encoding an ArsM homolog was identified. The analysis of the nucleotide and deduced amino acid sequence was performed using Nucleotide BLAST and BLASTX. Multiple alignment of ArsM homolog sequences was performed using Clustal Omega (http://www.ebi.ac.uk/ Tools/msa/clustalo/). To express the BlarsM gene in E. coli, a 813 bp fragment excluding the stop codon was amplified from Bacillus sp. CX-1 genomic DNA by using the primer pair P arsM -F and P arsM -R (Supporting Information Table S1 ). After digestion with NdeI and XhoI, the PCR product was cloned into NdeI/XhoI-digested vector pET29a(1) to generate plasmid pET29a-BlarsM. The plasmid pET29a(1) and pET29a-BlarsM were respectively transformed into the Ashypersensitive E. coli strain AW3110(DE3) (᭝arsRBC). As(III) resistance and methylation assays were performed as previously described (Huang et al., 2016) .
Real-time qPCR analysis
Overnight cultures were diluted to an OD 600 of 0.01 into 25 ml LB medium with different concentrations of As(III) (0, 25, 100, 250 and 500 lM) and grown at 378C to midexponential phase (OD 600 %0.8). Total RNA was extracted from cells in 4.5 ml of culture medium using a Bacterial RNA kit (Omega). The cDNA was obtained by using HiScript II Q Select RT SuperMix for qPCR (1gDNA wiper) (Vazyme) and served as the template for real-time qPCR (RT-qPCR) analysis. The primers for RT-qPCR were P qarsM -F and P qarsM -R (Supporting Information Table S1 ) for the BlarsM gene, P qgyrB -F and P qgyrB -R (Supporting Information  Table S1 ) for the reference gene (BlgyrB). The RT-qPCR was performed on a CFX96 Thermocycler (Bio-Rad) with SYBR Green Master Mix (Vazyme) and RT-qPCR primers. The specificity of single-target amplification was checked by analysis of the post-PCR melting curves. Relative changes in gene expression were calculated by using the 2 -DDCn method.
Site-directed mutagenesis
The fragment of wild-type BlarsM was amplified using the primer pair P arsM -F and P arsM -R and then cloned into pClone007 blunt vector (1911bp, TsingKe, China) to produce plasmid pClone007-BlarsM as the template for mutant construction. Site-directed mutagenesis of BlarsM was performed using a Takara MutanBEST kit with seven mutagenesis primer pairs (Supporting Information Table S1 ). Three conserved cysteines (Cys10, Cys145, Cys195) and three other non-conserved cysteines (Cys11, Cys193, Cys268) were replaced individually by serine. The P50C mutant was generated by replacing codon 50 (proline) in wide type BlarsM to cysteine. The nucleotide sequence of the quadruple C10S/C11S/C193S/C268S mutant was synthesized by Genscript Biotechnology Co., Ltd. (China). After site-directed mutagenesis was confirmed by DNA sequencing, each fragment of mutants was digested with NdeI and XhoI and cloned into pET29a(1) to produce plasmids pET29a-C10S, pET29a-C145S, pET29a-C195S, pET29a-C11S, pET29a-C193S, pET29a-C268S, pET29a-P50C and pET29a-C10S/C11S/C193S/C268S respectively.
Protein purification and methylation assays
Wild-type BlArsM and its mutants were over-expressed in E. coli strain BL21 (DE3). Protein purification was carried out following the procedures below. Cells bearing the expression plasmid were inoculated into 400 ml of LB medium with 50 lg ml 21 kanamycin and incubated at 378C to OD 600 of 0.6, at which point 0.3 mM Isopropyl b-D-1-Thiogalactopyranoside (IPTG) was added into the culture medium. After induction overnight at 168C, cells were harvested by centrifugation and washed twice with 20 ml of refrigerator-chilled buffer A consisting of 20 mM Na 3 PO 4 , 0.5 M NaCl, pH 7.4. The washed cells were suspended in 25 ml of buffer A and lysed on ice by ultrasonic cell disruption (XO-650D; Xianou). Membranes and unbroken cells were removed by centrifugation at 12,000 rpm at 48C for 40 min. The supernatant was filtered through a 0.45 mm MCE syringe filter (ASD, China) and loaded onto a 5 ml Ni-NTA agarose column (Cwbio, China), which was pre-equilibrated with 50 ml of buffer A containing 10 mM imidazole. The column was washed with 50 ml of buffer A containing 20 mM imidazole and eluted with 20 ml of buffer A containing 200 mM imidazole. The purified protein was identified by sodium-dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Protein concentration was determined at 280 nm by a Nanodrop-2000c spectrophotometer (Thermo Scientific).
Methylation of As(III) by cells of E. coli expressing BlarsM genes was assayed as previously described (Dheeman et al., 2014) . Methylation activities of purified BlArsM proteins with As(III) or MAs(III) as the substrate were assayed at 308C in 20 mM PBS buffer (20 mM KH 2 PO 4 , 20 mM Na 2 HPO 4 , 0.15 M NaCl, pH 7.4) containing 1 mM SAM and 8 mM GSH, and the reactions were terminated by the addition of 10% (v/v) H 2 O 2 . The oxidized solution samples were filtered through 0.22 lm MCE syringe filters and used for HPLC-ICP-MS analysis.
Homology model of BlArsM structure
The BlArsM homology model built on the unliganded structure of Chlamydomonas reinhardtii (CrArsM) (PDB ID: 5EVJ) structure has been deposited in PDB. The model for apo-BlArsM was built using a fully automated protein structure homology modeling server SWISS-MODEL (http:// swissmodel.expasy.org/) (Kiefer et al., 2009) . The model quality was estimated based on the QMEAN scoring function 0.39, which is within the acceptable rang (Benkert et al., 2011) . The BlArsM model structure was built with residues 68-231 (residue numbers based on the BlArsM sequence) from the structure of CrArsM as a template, and the final homology model incorporated 164 of those 271 residues. As(III) was modeled into the apo structure using known bond distance from As(III)-bound CrArsM structure. In silico GSH was docked into the As(III) binding site using the PATCHDOCK server (Schneidman-Duhovny et al., 2005) . PyMOL v1.3 was used to visualize the structural models (DeLano, 2001; Peter et al., 2006) .
Nucleotide sequence accession numbers
The draft genome and sequences of the 16S rRNA gene, arsM and gyrB from strain CX-1 have been submitted to the GenBank database under the accession numbers NCTZ00000000, KY234379, KY940033 and KY940034 respectively.
